This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nencioni, L Articles by Rappuoli, R Search for Related Content PubMed PubMed Citation Articles by Nencioni, L Articles by Rappuoli, R

 Previous Article  |  Next Article 

Infect Immun. 1991 February; 59(2): 625-630

Properties of pertussis toxin mutant PT-9K/129G after formaldehyde treatment.

Sclavo Research Center, Siena, Italy.

ABSTRACT

Formaldehyde treatment is a method routinely used to detoxify diphtheria, tetanus, and pertussis toxins as well as other molecules suitable for vaccine production. To investigate whether chemical detoxification alters the immunological properties of vaccine components, we have treated the pertussis toxin mutant PT-9K/129G with formaldehyde and tested the properties of the resulting molecules. Very low concentrations of formaldehyde stabilize the molecule without affecting the physicochemical and immunological parameters. Increasing doses of formaldehyde abolish the mitogenic and hemagglutinating activities of PT-9K/129G. At the same time, the molecule loses the ability to be recognized by a monoclonal antibody specific for a major protective epitope on the S1 subunit of pertussis toxin and its affinity for anti-pertussis toxin polyclonal antibodies is also reduced. In marked contrast, the ability of PT-9K/129G to be recognized by human T-cell clones is not affected by Formalin treatment. In vivo, the formaldehyde-treated molecules induce amounts of specific antibodies comparable with those of untreated molecules but significantly lower levels of toxin-neutralizing antibodies. Furthermore, the formaldehyde-treated molecules also show a reduced protective activity in the intracerebral challenge assay.

This article has been cited by other articles:

• Keller, J. E. (2008). Characterization of New Formalin-Detoxified Botulinum Neurotoxin Toxoids. CVI 15: 1374-1379 [Abstract] [Full Text]  
• Kubler-Kielb, J., Liu, T.-Y., Mocca, C., Majadly, F., Robbins, J. B., Schneerson, R. (2006). Additional Conjugation Methods and Immunogenicity of Bacillus anthracis Poly-{gamma}-D-Glutamic Acid-Protein Conjugates.. Infect. Immun. 74: 4744-4749 [Abstract] [Full Text]  
• Metz, B., Kersten, G. F. A., Hoogerhout, P., Brugghe, H. F., Timmermans, H. A. M., de Jong, A., Meiring, H., Hove, J. t., Hennink, W. E., Crommelin, D. J. A., Jiskoot, W. (2004). Identification of Formaldehyde-induced Modifications in Proteins: REACTIONS WITH MODEL PEPTIDES. J. Biol. Chem. 279: 6235-6243 [Abstract] [Full Text]  
• Nascimento, I. P., Dias, W. O., Mazzantini, R. P., Miyaji, E. N., Gamberini, M., Quintilio, W., Gebara, V. C., Cardoso, D. F., Ho, P. L., Raw, I., Winter, N., Gicquel, B., Rappuoli, R., Leite, L. C. C. (2000). Recombinant Mycobacterium bovis BCG Expressing Pertussis Toxin Subunit S1 Induces Protection against an Intracerebral Challenge with Live Bordetella pertussis in Mice. Infect. Immun. 68: 4877-4883 [Abstract] [Full Text]